Ibritumomab Intravenous and Larotrectinib Capsules
Determining the interaction of Ibritumomab Intravenous and Larotrectinib Capsules and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: ibritumomab
Brand name: Y-90 Zevalin, In-111 Zevalin
Synonyms: Ibritumomab, Ibritumomab Tiuxetan
Generic Name: larotrectinib
Brand name: Vitrakvi
Synonyms: Larotrectinib
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Ibritumomab Intravenous-Larotrectinib Oral Solution
- Ibritumomab Intravenous-Larotrectinib Sulfate
- Ibritumomab Intravenous-Lartruvo
- Ibritumomab Intravenous-Larynex
- Ibritumomab Intravenous-Laryng-O-Jet
- Ibritumomab Intravenous-Laryngesic
- Larotrectinib Capsules-Ibritumomab Tiuxetan
- Larotrectinib Capsules-Ibrutinib
- Larotrectinib Capsules-Ibrutinib Capsules
- Larotrectinib Capsules-Ibrutinib Tablets
- Larotrectinib Capsules-Ibu
- Larotrectinib Capsules-IBU Tablets